SANOFI AVENTIS, S.A. secures contract for Medicinal Products for the Cardiovascular System - Supply of Humanian Human Use Medicines containing the active ingredients Evolocumab, Alirocumab and Inclisir will destined for the centers of the field of Valencian public health, through the negotiated procedure without advertising by exclusivity

Spain, June 30 -- Spain based SANOFI AVENTIS, S.A. has secured contract from Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad for Medicinal Products for the Cardiovascular System - Supply of Humanian Human Use Medicines containing the active ingredients Evolocumab, Alirocumab and Inclisir will destined for the centers of the field of Valencian public health, through the negotiated procedure without advertising by exclusivity. The value of the contract is worth 587227000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....